Our Team
Yolanda Palomo
Research Director
Yolanda has a background as a Clinical monitor specialising in clinical health research and specializes in translational research for rare diseases and new treatments for rare diseases.
She founded the Spanish Tuberous Sclerosis Association in 2000 and has been its president and director ever since.
She drafted the Tuberous Sclerosis Complex recommendation guidelines. She has also been involved in writing several publications on this rare disease.
She has collaborated in various oncology activities, such as patient and hospital selection in Tuberous Sclerosis with Novartis Oncology.
Collaborates in training and activities to raise awareness of rare diseases among medical students at the Complutense University of Madrid.
She has carried out and participated in training groups for patients and relatives with Tuberous Sclerosis. Together with other organisations, she participates in the group on refractory epilepsies in rare diseases.
She has been a speaker at many national congresses and conferences on rare diseases, as well as an organiser of national congresses on rare diseases.
She was a delegate for seven years (2001/2008) of FEDER (Spanish Federation of Rare Diseases) and was a member and collaborator of the FEDER Foundation for research into rare diseases. She was a member of the Board of Directors of the European TSC Association from 2007 to 2021.
Joaquín Morales
Founder and CEO
He has extensive experience in the world of business and entrepreneurship, working in the areas of leadership and management.
He is also currently CEO of Cañamo’s Farmland, a company specialising in indoor cannabis cultivation and the main supplier of Oils4cure‘s starting material.
He has extensive experience in cultivation processes, design and configuration of production facilities.
He has been responsible for the development of the entire starting material production area, including the design and construction of the facilities, development and implementation of the production processes, management and supervision of the quality and certification area.
He is also responsible for the end-to-end manufacturing design of investigational drugs, the coordination and quality control of the process, and coordinates the distribution logistics for the clinical trial phase.
Carmen Sever
Regulatory Affairs Officer
She has extensive experience in the area of clinical trial development for rare diseases and orphan drug development.
She has participated as a speaker at numerous congresses and conferences on Rare Diseases.
Member of the Board of Trustees of the FEDER Foundation for Rare Diseases Research (2015/2018).
She is a patient representative on the Clinical Research Ethics Committee of the Community of Madrid.